determination of radiation dose rates and urinary activity of patients received sodium iodide-131 for treatment of differentiated thyroid carcinoma [persian]
Authors
abstract
sodium iodide-131 is administrated for treatment of hyperthyroidism and thyroid cancer. iodine-131 has multiple routs of excretion (urine, saliva, sweat, milk, feces, exhalation) from the body. patients receiving sodium iodide-131 therapy exposes other persons and the environment to unwanted radiation and contamination. the major source of radiation dose from administration of iodine-131 is external radiation, also there is a potential for exposure via contamination. precautions are necessary to limit the radiation dose to family members, nursing staff and members of public and waste treatment workers to less than 1msv. patients received sodium iodide-131 may come into close contact with other persons. in order to derive appropriate recommendations, dose rates were measured from the anterior mid-trunk of 29 patients in the upright position within 15 minutes post-dose administration at 3 meters and just before they left the nuclear medicine department at 0.5, 1 and 3 meters. we have also measured urinary iodide excretion in 29 patients to estimate sodium iodide-131 urinary excretion pattern in iranian patients. based on results, the maximum cumulative dose to nursing staff was on third day (leaving day) still less than recommended dose by icrp. the cumulative dose of family members will be more but regarding the time and distance in close contact it will also be less than recommended dose by icrp. radiation dose rate was decreased significantly on third day. the urinary excretion patterns in all patients were similar. the urinary excretion rate-time curve in all patients showed multiple peaks due to retention and redistribution of iodine-131 or entrohepatic cycle of radioiodinated thyroid hormones, which didn’t allow calculation of urinary excretion rate constant. the results also showed that 67 hours post administration of sodium iodide-131 about 70% of radiopharmaceutical was excreted through urine, 28% physically decayed or eliminated through other biological routes.
similar resources
Determination of radiation dose rates and urinary activity of patients received Sodium Iodide-131 for treatment of differentiated thyroid carcinoma [Persian]
Sodium Iodide-131 is administrated for treatment of hyperthyroidism and thyroid cancer. Iodine-131 has multiple routs of excretion (Urine, saliva, sweat, milk, feces, exhalation) from the body. Patients receiving Sodium Iodide-131 therapy exposes other persons and the environment to unwanted radiation and contamination. The major source of radiation dose from administration of Iodine-131 ...
full textBone marrow radiation dosimetry of high dose 131I treatment in differentiated thyroid carcinoma patients
Background: Radiation absorbed dose to the red bone marrow, a critical organ in the therapy of thyroid carcinoma, is generally kept below 2 Gy for non-myeloablative therapies. The aim of this study was to calculate bone marrow radiation dose by using MIRDOSE3 package program and to optimize the safe limit of activity to be administered to the thyroid cancer patients. Materials and Methods: In t...
full textEffect of administrated activity, admission number and TSH level on radiation retention curve of patients taking iodine-131 therapy for differentiated thyroid carcinoma: Looking beyond established regulations
Introduction: Retention of I-131 in the body of patients with differentiated thyroid carcinoma (DTC) has a direct effect on therapeutic outcome of radioiodine therapy. There are several factors that may influence retention time of radioiodine in the body of these patients. In this study we are going to assess effects of administered radioiodine activity, serum thyroid stimulati...
full textcomparison of zoe and vitapex for canal treatment of necrotic primary teeth
چکیده ندارد.
15 صفحه اولMeasurement of the Radiation Dose Rates of Patients Receiving Treatment with I-131 Using Telescopic Radiation Survey Meter
Introduction In order to discharge the patients receiving treatment with large radiation doses of 131I for thyroid cancer, it is necessary to measure and evaluate the external dose rates of these patients. The aim of the study was to assess a new method of external dose rate measurement, and to analyze the obtained results as a function of time. Materials and Methods In this study, a telescopic...
full textbone marrow radiation dosimetry of high dose 131i treatment in differentiated thyroid carcinoma patients
background: radiation absorbed dose to the red bone marrow, a critical organ in the therapy of thyroid carcinoma, is generally kept below 2 gy for non-myeloablative therapies. the aim of this study was to calculate bone marrow radiation dose by using mirdose3 package program and to optimize the safe limit of activity to be administered to the thyroid cancer patients. materials and methods: in t...
full textMy Resources
Save resource for easier access later
Journal title:
iranian journal of nuclear medicinePublisher: tehran university of medical sciences
ISSN 1681-2824
volume 12
issue 1 2004
Hosted on Doprax cloud platform doprax.com
copyright © 2015-2023